Delivery Order SPE2DB22D2007-SPE2DB24FJ4FM
Award Date
7/16/24
Potential Completion Date
7/17/24
Potential Value
$5.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,391 units of Vyvanse 20 mg capsules. The contract has a firm fixed price of $1,931.73 and a completion date of August 9, 2024. The award is not associated with any set-aside program. This delivery order is part of a broader Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $12,965.44 firm fixed price contract is for the supply of 4,565,600,669 units of the prescription medication Vyvanse 70 mg capsules. The order has an ultimate completion date of August 27, 2024 and was awarded on August 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Vyvanse 20 mg capsules. The contract has a firm fixed price of $1,724.00 and an ultimate completion date of August 14, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,362.54, is for the delivery of 4,566,359,456 units of Vyvanse 20 mg capsules. It is a firm fixed-price, delivery order contract with an ultimate completion date of November 7, 2024. The contract was awarded on November 6, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Vyvanse 20 mg capsules. The contract, valued at $4,297.28, is a Firm Fixed Price Delivery Order with a completion date of June 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, to provide a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $6,120.52 firm fixed-price contract is for the supply of Vyvanse 50mg capsules, a prescription medication. The ultimate completion date is September 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $7,471.24, is for the delivery of 4,566,626,257 units of the 20 mg capsule form of the prescription drug Vyvanse. The contract has a firm fixed price and is set to expire on December 5, 2024. This appears to be a specific delivery order placed under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of 4,565,529,755 units of Vyvanse 20 mg capsules. The contract has a firm fixed price and a ceiling value of $1,473.92. It is not set aside for any specific business type. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, worth up to $999,999,999 through December 2025, for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 4,566,538,444 units of Vyvanse 20 mg capsules, with a ceiling value of $5,507.83. The contract is a firm fixed-price delivery order with a period of performance through November 25, 2024. The order was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen, a for-profit corporation, holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp (AmerisourceBergen), a major pharmaceutical distributor. The $1,641.92 contract is for the supply of 4,565,712,501 units of the prescription drug Vyvanse 40 mg capsule. The order has a firm fixed price and an ultimate completion date of September 9, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with...